Anoro vs. Ultibro: COPD Treatment Differences Explained

Anoro and Ultibro are both medications used to treat chronic obstructive pulmonary disease (COPD). However, they differ in their active ingredients and how they are taken.

Anoro contains two bronchodilators, umeclidinium and vilanterol, which work by relaxing the muscles around the airways to improve breathing. Anoro is taken once a day using a dry powder inhaler.

Ultibro contains two bronchodilators, indacaterol and glycopyrronium, which also work by relaxing the muscles around the airways to improve breathing. Ultibro is taken once a day using a combination inhaler.

While both medications are effective in treating COPD, the choice between them may depend on individual patient factors such as drug allergies, severity of COPD symptoms, and preferences for inhaler type. It is important to consult with a healthcare provider to determine which medication is best for each individual.